|
they have recently found triple negative tumors to be
be most sensitive to cisplatin (heard at two major bc conferences, one in July, one in October--very recent work and I don't recall if it has been published yet) and a subset are EGFR positive and thus treatable with Tarceva as well.
Has she been BRCA tested?
Since they may be testing for EGFR to see if Tarceva is indicated, perhaps they would do additional IHC testing to look for other targets as there are clinical trials for all sorts of new targeted therapies
PPAR inibitors, mTor inhibitors, HDAC inhibitors, etc.
Is she near a major cancer center?
|